Jan Kaiserle

In the years following the Supreme Court’s landmark 2022 Dobbs decision that overturned federal abortion rights, a striking and counterintuitive trend has emerged across the United States. While numerous states moved swiftly to enact severe restrictions or outright bans on the procedure, the total

A groundbreaking artificial intelligence model developed by researchers at the Mayo Clinic is now capable of doubling the early diagnosis rate of advanced chronic liver disease, achieving this remarkable feat by analyzing data from a standard electrocardiogram (ECG). This pioneering innovation

A comprehensive evaluation of specialized oncology care has provided definitive evidence that the rigorous process of certification directly translates into a higher standard of treatment and significantly improved patient outcomes. For individuals navigating the complexities of a hereditary breast

In the challenging landscape of pediatric oncology, researchers from St. Jude Children's Research Hospital have illuminated a new path forward with a highly promising combination therapy designed to combat atypical teratoid rhabdoid tumor (ATRT), a rare and exceptionally aggressive form of brain

For millions grappling with an illness that profoundly saps their vitality without a clear biological explanation, the search for answers has been a long and frustrating journey. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has long been an enigma, a constellation of debilitating

A landmark development in medical imaging is poised to transform the diagnosis of diabetic retinopathy by offering a non-invasive, AI-powered method to replace a complex and uncomfortable procedure that has long been the standard of care. This innovation addresses a critical global health issue, as

In the high-stakes world of biopharmaceutical development, the line between a groundbreaking success and a costly failure is often defined by the unforgiving logic of statistical significance, a reality Nektar Therapeutics recently confronted with its autoimmune drug, rezpegaldesleukin. The company

In a healthcare landscape defined by unprecedented staffing shortages and the rapid integration of digital health solutions, the conventional methods of talent acquisition are proving increasingly inadequate. The traditional, high-volume approach, often prioritizing speed over substance, has

The intricate dance of cellular machinery required to produce life-saving biologic therapies has long been dictated by a rhythm of chance, but a new era of genomic precision is fundamentally changing the tempo of drug development. For decades, the biopharmaceutical industry has grappled with a

A groundbreaking new methodology that harnesses the power of artificial intelligence to analyze retinal fundus images is poised to revolutionize how medical professionals assess brain health, offering a non-invasive, cost-effective, and rapid alternative to traditional neuroimaging techniques. This